Zobrazeno 1 - 10
of 156
pro vyhledávání: '"CO Hanemann"'
Autor:
Matthias A. Karajannis, A Taylor, Diana Baralle, Rosalie E. Ferner, A Gomes, Dave Viskochil, J Toelen, Rianne Oostenbrink, Christopher L. Moertel, Laura Papi, Conxi Lázaro, H Wu, Michael D. Wilson, Shay Ben-Shachar, Pierre Wolkenstein, Sirkku Peltonen, Plotkin, P Joly, Dominique C. Pichard, Michael Fisher, Steinke-Lange, T Frébourg, P Ciavarelli, H Hanson, Mia MacCollin, I Blanco, D Bessis, Meena Upadhyaya, C Cassiman, Dusica Babovic-Vuksanovic, Riccardi, Juha Peltonen, James H. Tonsgard, B Poppe, Katharina Wimmer, M Larralde, P Pancza, A Heiberg, Bruce R. Korf, Mautner, D. G. R. Evans, Robert Listernick, Tena Rosser, S Barbarot, Eva Trevisson, D Stevenson, M Anten, Eduard Serra, Miriam J. Smith, Christopher J Hammond, Susan M Huson, Yemima Berman, Marco Giovannini, C Mallucci, Anat Stemmer-Rachamimov, G Tadini, Robert A. Avery, N Rezende, Nicole J. Ullrich, CO Hanemann, SM Stivaros, Hildegard Kehrer-Sawatzki, A Parry, D Kroshinsky, Maurizio Clementi, JT Jordan, A Varan, Joanne Ngeow, A Mueller, G Zadeh, Michel Kalamarides, D Halliday, M Link, Elizabeth K. Schorry, Roger J. Packer, Vanessa L. Merker, David H. Gutmann, Arthur S. Aylsworth, Karin Soares Gonçalves Cunha, V-F Mautner, Amanda L. Bergner, David A. Stevenson, Eric Legius, L Le, M Ruggieri, Fred G. Barker, Ludwine Messiaen, Jan M. Friedman, J. Blakeley, Kaleb Yohay, Katherine A. Rauen, LO Rodrigues
Publikováno v:
Genetics in Medicine
Genetics in Medicine, 23(8), 1506-1513. Lippincott Williams & Wilkins
Genetics in Medicine, 23(8), 1506-1513. Lippincott Williams & Wilkins
PURPOSE: By incorporating major developments in genetics, ophthalmology, dermatology, and neuroimaging, to revise the diagnostic criteria for neurofibromatosis type 1 (NF1) and to establish diagnostic criteria for Legius syndrome (LGSS). METHODS: We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45cd2826f627d5badf189e97ab322203
https://orca.cardiff.ac.uk/id/eprint/143733/1/s41436-021-01170-5.pdf
https://orca.cardiff.ac.uk/id/eprint/143733/1/s41436-021-01170-5.pdf
Publikováno v:
Journal of the Peripheral Nervous System. 5:251-251
The hereditary demyelinating neuropathy Charcot-Marie-Tooth type 1A is caused by duplication or by point mutations of the PMP22 gene. Histopathological differences in these genotypes suggest distinct disease mechanisms. In the present investigation w
Publikováno v:
Journal of the Peripheral Nervous System. 5:251-251
Autor:
Wang JZ; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Landry AP; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Raleigh DR; Department of Radiation Oncology, Neurological Surgery, and Pathology, University of California San Francisco, San Francisco, California, USA., Sahm F; Department of Neuropathology, University Hospital Heidelberg and German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Walsh KM; Department of Neurosurgery, Duke University, Durham, North Carolina, USA., Goldbrunner R; Center of Neurosurgery, Department of General Neurosurgery, University of Cologne, Cologne, Germany., Yefet LS; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada., Tonn JC; Department of Neurosurgery, University Hospital Munich LMU, Munich, Germany., Gui C; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Ostrom QT; Duke Cancer Institute, Duke University School of Medicine, Durham, North Carolina, USA.; Central Brain Tumor Registry of the United States, Hinsdale, Illinois, USA.; Department of Neurosurgery, Duke University, Durham, North Carolina, USA., Barnholtz-Sloan J; Center for Biomedical Informatics & Information Technology (CBIIT), National Cancer Institute, Bethesda, Maryland, USA.; Trans Divisional Research Program (TDRP), Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute, Bethesda, Maryland, USA.; Central Brain Tumor Registry of the United States, Hinsdale, Illinois, USA., Perry A; Department of Pathology, University of California San Francisco, San Francisco, California, USA., Ellenbogen Y; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Hanemann CO; Peninsula Schools of Medicine, University of Plymouth University, Plymouth, UK., Jungwirth G; Division of Experimental Neurosurgery, Department of Neurosurgery, Heidelberg University, Heidelberg, Germany., Jenkinson MD; Department of Neurosurgery, The Walton Centre NHS Foundation Trust, Liverpool, UK.; Institute of Translational Medicine, University of Liverpool, UK., Tabatabai G; Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies,' Eberhard Karls University Tübingen, Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Tübingen, Germany., Mathiesen TI; Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., McDermott MW; Division of Neuroscience, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, USA.; Miami Neuroscience Institute, Baptist Health of South Florida, Miami, Florida, USA., Tatagiba M; Department of Neurosurgery, University of Tübingen, Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Tübingen, Germany., la Fougère C; Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies,' Eberhard Karls University Tübingen, Tübingen, Germany., Maas SLN; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Galldiks N; Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.; Institute of Neuroscience and Medicine (IMN-3), Research Center Juelich, Juelich, Germany., Albert NL; Department of Nuclear Medicine, Ludwig Maximilians-University of Munich, Munich, Germany., Brastianos PK; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, USA., Ehret F; Department of Radiation Oncology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health, Charité - Universitätsmedizin Berlin, Berlin, Germany., Minniti G; Department of Radiological Sciences, Oncology and Anatomical Pathology, Sapienza University of Rome, Rome, Italy., Lamszus K; Laboratory for Brain Tumor Biology, University Hospital Eppendorf, Hamburg, Germany., Ricklefs FL; Department of Neurosurgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Schittenhelm J; Department of Neuropathology, University Hospital Tübingen, Eberhard-Karls-University Tübingen, Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Tübingen, Germany., Drummond KJ; Department of Neurosurgery, The Royal Melbourne Hospital, Melbourne, Victoria, Australia., Dunn IF; Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA., Pathmanaban ON; Division of Neuroscience and Experimental Psychology, Manchester Centre for Clinical Neurosciences, Geoffrey Jefferson Brain Research Centre, University of Manchester, Manchester, UK., Cohen-Gadol AA; Department of Neurological Surgery, Indiana University, Indianapolis, Indiana, USA., Sulman EP; Department of Radiation Oncology, NYU Grossman School of Medicine, New York, New York, USA., Tabouret E; CNRS, INP, Inst Neurophysiopathol, Aix-Marseille University, Marseille, France., Le Rhun E; Department of Neurology & Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland., Mawrin C; Department of Neuropathology, University Hospital Magdeburg, Magdeburg, Germany., Moliterno J; Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, USA., Weller M; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland., Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Gao A; Department of Laboratory Medicine and Pathobiology, University Health Network, Toronto, Ontario, Canada., Yip S; Department of Pathology & Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Radiation Oncology, University Hospital, Munich, Germany.; German Cancer Consortium (DKTK), Munich, Germany., Niyazi M; Bavarian Cancer Research Center (BZKF), Munich, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Tübingen, Germany., Aldape K; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA., Wen PY; Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Short S; Leeds Institute of Medical Research, St James's University Hospital, Leeds, UK., Preusser M; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Nassiri F; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada., Zadeh G; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.; Division of Neurosurgery, Department of Surgery, University of Toronto, Toronto, Ontario, Canada.; MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, Ontario, Canada.
Publikováno v:
Neuro-oncology [Neuro Oncol] 2024 Oct 03; Vol. 26 (10), pp. 1742-1780.
Autor:
Dave F; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Herrera K; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Lockley A; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., van de Weijer LL; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Henderson S; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Sofela AA; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Hook L; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Adams CL; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Ercolano E; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Hilton DA; Department of Cellular and Anatomical Pathology, University Hospitals Plymouth NHS Trust, Derriford, Plymouth, PL6 8DH, UK., Maze EA; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Kurian KM; University of Bristol Medical School & North Bristol Trust, Southmead Hospital, Bristol, BS1 0NB UK, Bristol, BS1 0NB, UK., Ammoun S; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK. sylwia.ammoun@plymouth.ac.uk., Hanemann CO; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK. oliver.hanemann@plymouth.ac.uk.
Publikováno v:
Oncogene [Oncogene] 2024 Oct; Vol. 43 (41), pp. 3080.
Autor:
Dave F; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Herrera K; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Lockley A; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., van de Weijer LL; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Henderson S; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Sofela AA; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Hook L; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Adams CL; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Ercolano E; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Hilton DA; Department of Cellular and Anatomical Pathology, University Hospitals Plymouth NHS Trust, Derriford, Plymouth, PL6 8DH, UK., Maze EA; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK., Kurian KM; University of Bristol Medical School & North Bristol Trust, Southmead Hospital, Bristol, BS1 0NB UK, Bristol, BS1 0NB, UK., Ammoun S; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK. sylwia.ammoun@plymouth.ac.uk., Hanemann CO; University of Plymouth, Faculty of Health, The John Bull Building, Plymouth Science Park, Research Way, Plymouth, PL6 8BU, UK. oliver.hanemann@plymouth.ac.uk.
Publikováno v:
Oncogene [Oncogene] 2024 Oct; Vol. 43 (41), pp. 3049-3061. Date of Electronic Publication: 2024 Aug 23.
Autor:
Young CA; Walton Centre NHS Foundation Trust, Liverpool, UK.; Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK., Chaouch A; Greater Manchester Centre for Clinical Neurosciences, Salford, UK., Mcdermott CJ; Sheffield Institute for Translational Neuroscience, Sheffield, UK., Al-Chalabi A; Department of Basic and Clinical Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.; Department of Neurology, King's College Hospital, London, UK., Chhetri SK; Lancashire Teaching Hospital, Preston, UK., Talbot K; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK., Harrower T; Royal Devon and Exeter Foundation Trust Hospital, Exeter, UK., Orrell RW; Royal Free London NHS Foundation Trust, London, UK., Annadale J; Hywel Dda University Health Board, Carmarthen, UK., Hanemann CO; Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK., Scalfari A; Imperial College Healthcare NHS Trust, London, UK, and., Tennant A; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK., Mills R; Walton Centre NHS Foundation Trust, Liverpool, UK.; Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
Publikováno v:
Amyotrophic lateral sclerosis & frontotemporal degeneration [Amyotroph Lateral Scler Frontotemporal Degener] 2024 Aug; Vol. 25 (5-6), pp. 475-485. Date of Electronic Publication: 2024 Mar 11.
Autor:
Na J; Peninsula Medical School, Faculty of Health, University of Plymouth, Devon, United Kingdom., Shaji S; Peninsula Medical School, Faculty of Health, University of Plymouth, Devon, United Kingdom., Hanemann CO; Peninsula Medical School, Faculty of Health, University of Plymouth, Devon, United Kingdom. Electronic address: oliver.hanemann@plymouth.ac.uk.
Publikováno v:
EBioMedicine [EBioMedicine] 2024 Jul; Vol. 105, pp. 105211. Date of Electronic Publication: 2024 Jun 24.
Autor:
Purshouse K; Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, UK., Bulbeck HJ; Brainstrust, Cowes, UK., Rooney AG; Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK., Noble KE; Brain Tumour Research, Milton Keynes, UK., Carruthers RD; Beatson West of Scotland Cancer Centre, Glasgow, UK., Thompson G; Centre for Clinical Brain Sciences, The University of Edinburgh, Edinburgh, UK.; Department of Clinical Neurosciences, NHS Lothian, Edinburgh, UK., Hamerlik P; Division of Cancer Sciences, University of Manchester, Manchester, UK., Yap C; Clinical Trials and Statistics Unit, Sutton, UK., Kurian KM; Bristol Brain Tumour Research Centre, Bristol Medical School, University of Bristol, Bristol, UK., Jefferies SJ; Oncology Department, Addenbrooke's Hospital, Cambridge, UK., Lopez JS; Royal Marsden NHS Foundation Trust and the Institute of Cancer Research, Sutton, UK., Jenkinson MD; University of Liverpool & Walton Centre, Liverpool, UK., Hanemann CO; Peninsula Medical School, University of Plymouth, Plymouth, UK., Stead LF; Leeds Institute of Medical Research, University of Leeds, Leeds, UK.
Publikováno v:
Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2024 Apr; Vol. 50 (2), pp. e12979.
Autor:
Sundby RT; Pediatric Oncology Branch, National Cancer Institute, Bethesda, MD, USA., Rhodes SD; Division of Hematology/Oncology/Stem Cell Transplant, Department of Pediatrics, Herman B Wells Center for Pediatric Research, School of Medicine, Indiana University, Indianapolis, IN, USA., Komlodi-Pasztor E; Department of Neurology, MedStar Georgetown University Hospital, Washington, DC, USA., Sarnoff H; Research and Development, Infixion Bioscience, Inc., San Diego, CA, USA.; Patient Representative, REiNS International Collaboration, San Diego, CA, USA., Grasso V; Neural Stem Cell Institute, Rensselaer, NY, USA.; Patient Representative, REiNS International Collaboration, Troy, NY, USA., Upadhyaya M; Division of Cancer and Genetics, Cardiff University, Wales, UK., Kim A; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA., Evans DG; Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester Academic Health Sciences Centre (MAHSC), ERN GENTURIS, Division of Evolution, Infection and Genomics, The University of Manchester, Manchester, UK., Blakeley JO; Division of Neuro-Oncology, Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, MD, USA., Hanemann CO; Peninsula Medical School, University of Plymouth, Plymouth, UK., Bettegowda C; Department of Neurosurgery, School of Medicine, Johns Hopkins University, Baltimore, MD, USA.
Publikováno v:
Clinical trials (London, England) [Clin Trials] 2024 Feb; Vol. 21 (1), pp. 40-50. Date of Electronic Publication: 2023 Oct 31.